Fraserna Life Sciences

ABOUT FRASERNA
| /
TECHNOLOGY PLATFORM
Preclinical Study

Plasmid construction
Cell construction
Virus construction and packaging
Antigen and target design
Immunology
In-vitro pharmacology
In vivo pharmacology
Early toxicology
Tumor model
Clinical Study

Viral Vectors

Seed bank preparation
Process development
Process scale up
mRNA/LNP Platform

Seed bank preparation
Process development
Process scale up
Vaccine

Sterile Formulation

Formulation development
Sterile Formulation Manufacturing and Quality
Quality Platform

Methodology development and validation
Quality management consulting and services
Registration Submission
| /
CLINICAL CRO
Services

Advantages

Burgeoning Healthcare Infrastructure
Regulatory Reforms and Accelerated Approval Proces
Vast Patient Base for Specific Indications
Access to Untapped Data and Real-World Evidence
Collaboration and International Partnerships
Potential for Early Market Access
Challenges and Mitigation
| /
CRDMO SERVICES
Viral Vector Drugs

Product Design and Construction
Druggability Study
Pharmacology and Early Toxicology
Establishment and Control Testing of Cell Banks
Establishment and Control Testing of Virus Banks
Process Development
Process Scale-up
GMP Manufacture
Method Development and Quality Control
Stability Study
Preparation of Application Dossier
mRNA Drugs

Product Design and Construction
Druggability Study
Pharmacology and Early Toxicology
Establishment and Control Testing of Seed Banks
Process Development
Process Scale-up
GMP Manufacture
Method Development and Quality Control
Stability Study
Preparation of Application Dossier
| /
CONTACT US

One-stop Clinical CRO & CRDMO+ Platform for Viral Vectors and Nucleic Acids Drugs

FRASERNA

About Us

▼

——

Our one-stop service platform of viral vector and nucleic acid drugs to help customers from drug discovery, proof-of-concept study, preclinical study, to CMC development, commercialization, and regulatory filing including IND and BLA.

——

Why Fraserna

———

Learn More

We are a CRDMO and Clinical CRO company focusing on viral vector and nucleic acid drugs. We have state-of-the-art technology empowered by strong R&D capability and large-scale commercial production facilities in China and North America. The Shanghai facility is over 70000m² and has been opened to customers while the remaining is under accelerated construction.
Your technique, your know-hows, your protocols and your IP will be protected under our customer IP privacy protection procedures.

Tel: +1.778.980.3486 Email: contact@fraserna.com

复择纳 · 中国